Resources

Rigorous workouts lasting as little as three minutes may help prevent diabetes by helping control blood sugar, British researchers said last week. Short bursts of intense exercise every few days over just 2 weeks could dramatically cut the risk of diabetes and heart disease.

Cell biology Professor Romeo Ricci and his team have discovered a new signal transduction pathway that might play an important role in the promotion of type 2 diabetes.

In the United States, nearly 13 percent of adults age 20 and older have diabetes but 40 percent of them have not been diagnosed, according to epidemiologists from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

A couple of months ago we had a review of GLP-1 mimetic therapies and studies form the European Association for the Study of Diabetes (EASD) 44th Annual Meeting convened in Rome, Italy, September 8-11, 2008. Many of you emailed me asking for more information on what the latest research shows …

Approximately 24 million Americans suffer from diabetes. In addition to the consumption of diets high in fat and sugar, a new study suggests that the air you breathe may also be risky, due to increasing insulin resistance and inflammation.

In a study that addressed the issue of insulin sensitivity with respect to sleep disordered breathing (SDB), they sought to examine the relationship between SDB and insulin resistance. The results definitively link SDB to pre-diabetic changes in insulin production and glucose metabolism.

People on low-carbohydrate diets are more dependent on the oxidation of fat in the liver for energy than those on a low-calorie diet, researchers at UT Southwestern Medical Center have found in a clinical study.

A pill that could mean the end of insulin injections for diabetics is about to be tested in human trials. It will be taken twice a day and releases insulin into the body over several hours.

Intensive antihypertensive therapy leads to improved pregnancy outcomes in women with type 1 diabetes and microalbuminuria or nephropathy, Danish researchers report.

Trodusquemine (MSI-1436), is a new first in class diabetes drug that is early in its testing phase for treating diabetes by reducing weight which then lowers blood sugars, cholesterol and blood pressure.